SKI Market

A+| A| A-|

Indian Indices

Sensex

74,616.58 509.73
( 0.69%)

Global Indices

Nasdaq

46,689.37 163.69
(0.35%)

Dow Jones

6,632.05 28.36
(0.43%)

Hang Seng

53,529.44 115.76
(0.22%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

92.68 -0.34
(-0.37%)

EUR-INR

106.73 -0.59
(-0.55%)

GBP-INR

122.22 -0.80
(-0.65%)

JPY-INR

0.58 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

PVV Infra Ltd

Industry : Construction

BSE Code

ISIN Demat

Book Value()

536659

INE428B01021

5.3181959

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

5.56

52.99

EPS(TTM)

Face Value()

Div & Yield %

0.66

Back

Bafna Pharmaceuticals standalone net profit rises 19.08% in the September 2025 quarter

Nov 12,2025

Net profit of Bafna Pharmaceuticals rose 19.08% to Rs 3.12 crore in the quarter ended September 2025 as against Rs 2.62 crore during the previous quarter ended September 2024. Sales declined 12.03% to Rs 35.47 crore in the quarter ended September 2025 as against Rs 40.32 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	35.47	40.32	-12
OPM %	12.04	9.42	-
PBDT	4.59	4.20	9
PBT	3.12	2.62	19
NP	3.12	2.62	19

74,616.58 509.73 ( 0.69%)

46,689.37 163.69 (0.35%)

6,632.05 28.36 (0.43%)

53,529.44 115.76 (0.22%)

10,436.29 71.50 (0.69%)

92.68 -0.34 (-0.37%)

106.73 -0.59 (-0.55%)

122.22 -0.80 (-0.65%)

0.58 0.00 (-0.50%)